Podcast - Quality by Design: Where We Stand Now - - BioPharm International

ADVERTISEMENT

Podcast - Quality by Design: Where We Stand Now





Add this Podcast feed to your media player



Quality by Design: Where We Stand Now

On what aspects of Quality by Design is there now consensus within the industry and regulatory bodies, and what remains to be sorted out?

Join Laura Bush, Editor in Chief of BioPharm International and John Towns, Senior Director of Global CMC Regulatory Affairs at Eli Lilly, as they discuss the current state of QbD.



Click here to go to the main podcast page >>>

Related Links:
Quality by Design for Biotechnology Products—Part 1: A PhRMA Working Group's advice on applying QbD to biotech.

Convincing the Skeptics

Quality by Design A-MAb Case Study Challenges Conventional Thinking
blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

FDA Panel Unanimously Backs Secukinumab for the Treatment of Psoriasis
October 22, 2014
Roche to Expand and Improve its Basel Site
October 22, 2014
Pall ForteBio Releases Bioprocessing Contamination Detection Kit
October 22, 2014
EMA Works to Speed Up Ebola Treatment
October 20, 2014
Amgen Sues Sanofi and Regeneron over Patent for mAb Targeting PCSK9
October 20, 2014
Author Guidelines

Click here